Last Updated: June 22, 2026

MERREM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Merrem patents expire, and what generic alternatives are available?

Merrem is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MERREM is meropenem. There are thirty-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Merrem

A generic version of MERREM was approved as meropenem by ACS DOBFAR on October 26th, 2011.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MERREM?
  • What are the global sales for MERREM?
  • What is Average Wholesale Price for MERREM?
Summary for MERREM
US Patents:0
Applicants:1
NDAs:1
Drug Prices: Drug price information for MERREM
What excipients (inactive ingredients) are in MERREM?MERREM excipients list
DailyMed Link:MERREM at DailyMed
Recent Clinical Trials for MERREM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Johns Hopkins UniversityPhase 2
Hoffmann-La RochePhase 1

See all MERREM clinical trials

US Patents and Regulatory Information for MERREM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer MERREM IV meropenem INJECTABLE;INJECTION 050706-001 Jun 21, 1996 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pfizer MERREM IV meropenem INJECTABLE;INJECTION 050706-003 Jun 21, 1996 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.